"Retinal Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases involving the RETINA.
- Retinal Diseases
- Disease, Retinal
- Diseases, Retinal
- Retinal Disease
Below are MeSH descriptors whose meaning is more general than "Retinal Diseases".
Below are MeSH descriptors whose meaning is more specific than "Retinal Diseases".
This graph shows the total number of publications written about "Retinal Diseases" by people in this website by year, and whether "Retinal Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Retinal Diseases" by people in Profiles.
Delineating the Clinical Phenotype of Patients With the c.629C>G, p.Pro210Arg Mutation in Peripherin-2. Invest Ophthalmol Vis Sci. 2022 07 08; 63(8):19.
Combined Hamartoma of the Retina and Retinal Pigment Epithelium in a Patient With Fragile X Syndrome. J Pediatr Ophthalmol Strabismus. 2022 Jul-Aug; 59(4):e39-e41.
Ocular malignancies treated with iodine-125 low dose rate (LDR) brachytherapy at a single high-volume institution: A retrospective review. Med Dosim. 2022 Autumn; 47(3):273-279.
Prph2 disease mutations lead to structural and functional defects in the RPE. FASEB J. 2022 05; 36(5):e22284.
Functional Evaluation of Splicing for Variants of Uncertain Significance in Patients with Inherited Retinal Diseases. Genes (Basel). 2021 06 29; 12(7).
Degradation of Photoreceptor Outer Segments by the Retinal Pigment Epithelium Requires Pigment Epithelium-Derived Factor Receptor (PEDF-R). Invest Ophthalmol Vis Sci. 2021 02 01; 62(2):30.
Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal Diseases. Int J Mol Sci. 2020 Dec 04; 21(23).
mTORC1 and mTORC2 expression in inner retinal neurons and glial cells. Exp Eye Res. 2020 08; 197:108131.
Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARa Agonists as Leads for Retinal Disorders. J Med Chem. 2020 03 26; 63(6):2854-2876.
Correlation Study of Apolipoprotein'a' with Diabetic Retinopathy in Patients of Type 2 Diabetes Mellitus with Retinopathy. J Assoc Physicians India. 2020 Jan; 68(1):49.